16 September 2026
Publication
Together with The Native Antigen Company, PUXANO used cryo-electron microscopy to investigate the structure of Chikungunya virus-like particles (CHIKV-VLPs).
A recent study published in Cell Reports (Volume 44, Issue 8, August 26, 2025), titled “Antibody-mediated TGF-β1 activation for the treatment of diseases driven by deleterious T cell activity,” features contributions from PUXANO, highlighting our role in advancing innovative immunotherapy research.
This innovative work, led by Fanny Lambert, Jan Felix, Savvas Savvides, and their team, represents a significant advance in understanding TGF-β1 activation and its therapeutic potential.
Stay updated on the latest in protein design, AI-driven engineering, and groundbreaking research. Subscribe now to get exclusive insights and updates.